4.6 Review

Chronic hypnotic use: deadly risks, doubtful benefit

期刊

SLEEP MEDICINE REVIEWS
卷 4, 期 1, 页码 5-20

出版社

W B SAUNDERS CO LTD
DOI: 10.1053/smrv.1999.0076

关键词

hypnotics; epidemiology; mortality; hazard; triazolam; zolpidem; flurazepam

向作者/读者索取更多资源

In the United States, roughly 2/3 of all hypnotic prescriptions go to chronic users, who have taken hypnotics for an average of 5 years or move. Two large prospective epidemiological studies have shown that reported hypnotic rise, especially use 30 times per month, is associated with an excess hazard of death. Indeed, use of hypnotics 30 times per month is associated with a similar mortality hazard to smoking 1-2 packs of cigarettes per day. Moreover, the hypnotic user's wish to improve daytime function is usually unfulfilled. The preponderance of evidence is that hypnotics impair performance, cognition and memory, increase the risk of automobile accidents and fails and promote unfavourable changes in personality. Due to tolerance, the sleep-promoting effects of hypnotics appear to be lost with chronic use. With long-term use, there is little controlled evidence that hypnotics produce benefits of any sort. More study of long-term hypnotic effects by public agencies is needed, but available evidence weighs strongly against long-term prescribing (C) 2000 Harcourt Publishers Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据